Clinical Trials Logo

Steatorrhea clinical trials

View clinical trials related to Steatorrhea.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02957318 Completed - Obesity Clinical Trials

Effect of Potato Fiber on Appetite and Fecal Fat Excretion

POFIBA
Start date: September 2016
Phase: N/A
Study type: Interventional

Results have indicated that some dietary fibers increase fecal fat excretion and particularly viscous fibers suppress appetite sensation and reduce energy intake. Both these effects may contribute to body weight management. Aim: The aim of the study is to investigate the potential of 3-weeks daily intake of potato pulp (FiberBind), rhamnogalacturonan I isolated potato fiber (RG-I) vs. a low-fiber control (placebo) on satiety and fecal fat excretion in healthy adults. Furthermore, a number of secondary endpoints are investigated.

NCT ID: NCT01327703 Completed - Cystic Fibrosis Clinical Trials

Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Start date: April 2011
Phase: Phase 4
Study type: Interventional

This study by Aptalis (formerly Axcan) assesses the efficacy and safety of Panzytrat® 25,000 compared to Kreon® 25,000 in the control of steatorrhea in participants with cystic fibrosis (CF) and exocrine pancreatic insufficiency (EPI).

NCT ID: NCT01184378 Completed - Growth Clinical Trials

Tolerance and Digestibility of a New Formula in Healthy Infants

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The great majority of infants formula contain fats exclusively from vegetable oil. Nevertheless, the use of both vegetable and dairy lipids is on a real interest to obtain an infant formula closer to the nutritional composition of maternal milk.

NCT ID: NCT00676702 Completed - Pancreatitis Clinical Trials

A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

Start date: July 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the enzyme activity and safety of pancrelipase in patients with severe Exocrine Pancreatic Insufficiency (EPI)

NCT ID: NCT00662675 Completed - Cystic Fibrosis Clinical Trials

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness and safety of oral pancrelipase MT in the treatment of adult and pediatric/adolescent cystic fibrosis (CF) patients with clinical symptoms of exocrine pancreatic insufficiency (EPI).

NCT ID: NCT00572975 Completed - Cystic Fibrosis Clinical Trials

Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea

MBT
Start date: August 2006
Phase: Phase 4
Study type: Interventional

*The purpose of this study is to develop a more accurate, reliable, specific and more acceptable alternative clinical test to the 72-hour stool and diet collection for quantifying fat malabsorption in people with CF and pancreatic insufficiency.

NCT ID: NCT00559364 Completed - Clinical trials for Chronic Pancreatitis

Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

Start date: November 2007
Phase: Phase 3
Study type: Interventional

This study assesses the efficacy and safety of Viokase® 16 for the correction of steatorrhea (malabsorption of dietary fats) in patients with a history of exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatectomy. This study is sponsored by Aptalis Pharma (formerly Axcan).

NCT ID: NCT00217204 Completed - Cystic Fibrosis Clinical Trials

An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption

Start date: July 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of PANCREASE MT (pancrelipase microtablets) to improve steatorrhea (excessive excretion of fat in feces) in infants and toddlers with cystic fibrosis who have pancreatic insufficiency, and to assess whether the consistency of the microtablets is acceptable for swallowing in infants and toddlers